Startup M&A Poland 2026: Buying Psas & Scale-ups, Esops, Safes/clns, Control Rights & Uokik Triggers

Startup M&A Poland is entering a more active phase in 2026, supported in part by state-backed acceleration programmes run by the Polish Agency for Enterprise Development (PARP), which help encourage new company formation and, in turn, can generate fresh dealflow and exit opportunities. For foreign strategics, private equity and venture investors, acquiring a Polish scale-up is rarely as simple as signing a share purchase agreement, a popular startup vehicle, the Prosta Spółka Akcyjna (PSA), introduces dematerialised shares, flexible share classes and governance mechanics that reward careful drafting. Layered on top are employee incentive schemes (ESOPs), convertible instruments such as SAFEs and convertible loan notes (CLNs), and merger control notifications to the Office of Competition and Consumer Protection (UOKiK).

This practitioner guide walks through each of these pressure points in deal order, from entity choice and due diligence to closing mechanics and post-completion integration, so that buyers can price risk accurately and avoid the traps that generic summaries overlook.

Quick summary and deal snapshot for startup M&A Poland

Most buyers acquiring a Polish startup face four recurring questions: which transaction route to use, how employee options behave on a change of control, what happens to outstanding convertible instruments at closing, and whether a UOKiK filing is required. The answers are rarely automatic. Polish law does not accelerate ESOP options on a sale unless the plan says so; SAFEs and CLNs do not convert “by default”, their treatment depends on documentation and shareholder approvals; and even a modest target can trigger merger control where the parties’ combined turnover meets statutory thresholds. The PSA form, while founder-friendly, carries its own share-register and dematerialisation mechanics that must be verified in diligence.

Six immediate actions for any buyer approaching startup M&A Poland:

• Confirm the target’s corporate form (PSA, sp. z o.o. or spółka akcyjna) and pull the current KRS/eKRS extract.
• Obtain a complete, reconciled cap table, including all convertible instruments and ESOP grants.
• Decide early between a share and asset structure based on liabilities, consents and tax.
• Map ESOP acceleration and buyout mechanics before signing, not at closing.
• Assess whether combined turnover triggers a UOKiK notification and build conditionality into the timetable.
• Secure representations and escrow arrangements covering outstanding SAFEs, CLNs and any disputed equity.

Polish company types and why PSAs matter for startup M&A Poland

Understanding the target’s legal form is the foundation of any Polish acquisition. The three forms a buyer will most often encounter are the limited liability company (sp. z o.o.), the joint-stock company (spółka akcyjna, SA) and the simple joint-stock company (Prosta Spółka Akcyjna, PSA). Each sits within the framework of the Commercial Companies Code (Kodeks spółek handlowych), and the differences between them shape how shares transfer, how governance is structured and what consents a deal requires.

What is a Prosta Spółka Akcyjna (PSA)?

The PSA, available since 1 July 2021, is a company form designed with founders and early-stage investors in mind. Introduced to support innovative businesses, it allows flexible share classes, a low minimum share capital and digital share issuance, and it recognises contributions in the form of work or services rather than only cash. Its shares are dematerialised, they exist as entries in a share register (rejestr akcjonariuszy) rather than as paper certificates, which changes how ownership is verified and transferred. Official guidance on the PSA is published by the Ministry of Justice, and the company’s registration and filings are reflected in the National Court Register.

Key differences versus sp. z o.o. and joint-stock companies

The practical differences matter enormously for startup M&A Poland. In an sp. z o.o., ownership is held in “udziały” (participations) and transfers typically require signatures with notarially certified authenticity and may be subject to corporate consents under the articles. In a classic SA, shares are governed by more formal joint-stock rules and must themselves be registered in a share register maintained by an authorised entity. The PSA combines capital-raising flexibility with simpler governance and the ability to create bespoke share classes carrying different economic and voting rights.

Three features deserve particular attention from acquirers:

• Dematerialised shares. Ownership is evidenced by the share register, not certificates. A buyer must confirm the register is accurate and that the entity maintaining it is properly appointed.
• Flexible share classes. Founders often hold classes carrying preferential voting or veto rights, which must be identified and, where necessary, neutralised or bought out.
• Registry records. The KRS/eKRS extract reflects certain corporate changes but not every share-register movement, so diligence must reconcile both.

PSA acquisitions, share versus asset purchase: legal mechanics and practical choice

Every PSA acquisition in Poland begins with a structural decision: buy the shares of the company, or buy its assets. A share purchase delivers continuity, the legal entity, its contracts, intellectual property, licences and employees remain in place, but the buyer inherits the company’s liabilities. An asset purchase lets the buyer select what it wants and can help isolate historic liabilities, but it typically requires more third-party consents and can be less tax-efficient. The right answer depends on the liability profile, the number of contracts that need novating, employment considerations and the tax position of the sellers.

Deal mechanics for a share purchase in a PSA

In a share deal, the transfer of PSA shares is effected by agreement in documentary form and, critically, by updating the dematerialised share register maintained for the company; the transfer is effective against the company upon the register entry. Because the shares are not certificated, the register entry is the operative act evidencing ownership, making it essential that the buyer verifies who maintains the register and that entries are current. Depending on the charter and any shareholders’ agreement, a transfer may require board or general meeting approvals, or may be subject to pre-emption rights, tag-along or drag-along provisions.

A well-constructed share purchase agreement (SPA) for a PSA will address the registry update as a closing deliverable, include escrow arrangements to secure indemnity claims, and contain a full suite of warranties covering title to shares, the cap table, convertible instruments, IP ownership, employment and tax. Because the buyer steps into the company’s historic liabilities, the warranty and indemnity package, together with a sensible cap and basket, does much of the risk-allocation work.

Asset purchase in practice, when it is used and the tax and employment implications

An asset purchase is typically chosen where the buyer wants only a defined set of assets, for example, a product, specific IP and key contracts, and wishes to leave behind contingent or unknown liabilities. The trade-off is complexity: contracts and licences often require counterparty consent to assign, employees may transfer automatically where part of an establishment is transferred (or may need to be re-engaged), and VAT and transfer-tax considerations differ from a share deal. For startups whose value lies in IP and talent, the operational friction of re-papering relationships can be significant, which is why many buyers default to a share route unless a specific liability concern justifies otherwise.

Due diligence focus for Polish startups and PSAs

Due diligence in startup M&A Poland is where most value and most risk are discovered. Startups move fast and document lightly, so the diligence exercise must reconcile what the founders say with what the registers, contracts and plan documents actually provide.

Corporate and governance due diligence

The corporate workstream should examine the PSA charter, any shareholders’ agreement, the full cap table and, crucially, the dematerialised share register. Buyers must confirm that share-register entries match the cap table, that the entity maintaining the register is validly appointed, and that there are no undisclosed share classes carrying veto or preference rights. The KRS/eKRS extract should be cross-checked against internal records, since the court register and the share register serve different functions. Any discrepancy between stated and registered ownership is a red flag that must be resolved before signing.

Intellectual property and technology

For technology startups, IP ownership is the deal. Diligence must confirm that all code, designs and inventions have been validly assigned to the company by founders, employees and contractors, and that open-source components do not impose incompatible licence obligations. Hosted data locations and cloud arrangements should be mapped for both continuity and data-protection compliance.

Employment and equity incentives

Employment diligence should capture ESOP plan documentation, individual option agreements, acceleration triggers and any on-target earnings or bonus obligations. Because equity incentives interact directly with the purchase price and the cap table, the buyer must understand exactly how many options are outstanding, their vesting status and whether a change of control affects them.

Contracts, data protection and regulatory licences

The remaining workstream covers material customer and supplier contracts (including change-of-control clauses), GDPR compliance and processing arrangements, and any sector-specific licences the target relies upon.

A focused red-flag checklist for PSA targets:

• Share register and cap table do not reconcile, or the register maintainer is unclear.
• Undisclosed share classes carrying founder vetoes or preferential rights.
• Incomplete IP assignments from founders, employees or contractors.
• Outstanding SAFEs or CLNs not reflected in the cap table.
• ESOP grants with ambiguous vesting or acceleration terms.
• Change-of-control termination rights in key customer contracts.
• GDPR gaps or unmapped cross-border data transfers.

ESOPs and employee incentives, acceleration, tax and treatment at closing

Employee equity is one of the most commonly mishandled aspects of startup M&A Poland. Founders and early employees frequently hold options or phantom equity whose treatment on a sale is governed entirely by the plan documents, not by any automatic statutory mechanism.

Common ESOP structures in Poland and enforcement

Polish startups use a range of incentive structures, including option plans granting the right to acquire shares, phantom or cash-settled schemes, and direct share awards. The enforceability and mechanics of each depend on how the plan is drafted and how it interacts with the company’s charter and share classes. In a PSA, the ability to create bespoke share classes can make equity incentives easier to implement, but it also means a buyer must read each plan carefully to understand what the holder is actually entitled to receive.

Do options accelerate on a change of control?

This is the single most important ESOP question for a buyer, and the answer is clear: Polish law does not automatically accelerate options on a change of control. Acceleration occurs only where the option plan or the individual option agreement expressly provides for it. If acceleration is provided, the buyer needs to understand its cost and cap-table impact; if it is not, the buyer may wish to negotiate acceleration, cash-out or roll-over mechanics directly with holders. In every case, implementing the chosen treatment usually requires consents and sometimes buyout arrangements that should be documented at signing rather than improvised at closing. Specific plan interpretation should be confirmed with local counsel.

Tax consequences for employees and buyers

The tax position depends heavily on the instrument and the timing of any taxable event. Whether a gain is characterised as employment income or as a capital gain affects both the rate and who bears the burden, and the timing of taxation can turn on whether the holder receives shares or cash. Poland operates specific rules on the deferral of taxation for certain qualifying incentive schemes, but the conditions are technical and fact-specific. High-level guidance is available via the Polish finance portal, but equity tax outcomes should be confirmed by a tax adviser, ideally with a pre-closing ruling where material.

Buyers frequently use gross-up arrangements, deferred consideration or structured cash-outs to manage employee tax exposure and to keep key talent motivated through the transition.

A model checklist for negotiating ESOP treatment at signing and closing:

• Confirm vesting status of every grant and whether acceleration applies.
• Agree acceleration, cash-out or roll-over mechanics for each holder category.
• Quantify the cap-table and purchase-price impact of ESOP settlement.
• Build retention pools and new incentive grants for key employees.
• Address tax timing, gross-ups and any required pre-closing rulings.
• Secure the consents needed to implement the chosen treatment.

SAFEs and convertible loans (CLNs), closing treatment and negotiation points

Convertible instruments are common in early-stage financing, and their treatment at closing is a frequent source of friction in startup M&A Poland. The common misconception, repeated in generic AI summaries, is that a SAFE “automatically converts” on an acquisition. In Poland, that is not the case: conversion is governed by the instrument’s terms and by the corporate approvals needed to issue shares.

Typical instruments used in Polish startups

Polish scale-ups commonly carry SAFEs (simple agreements for future equity), convertible loan notes and convertible notes. Each sits somewhere on a spectrum between debt and equity, and each contains its own trigger events, discount and valuation-cap mechanics, and maturity provisions. Because these instruments were often drafted on foreign templates, their interaction with Polish corporate law must be checked carefully.

How they are treated at closing, examples and problems

At closing, outstanding SAFEs and CLNs typically resolve in one of three ways: conversion into shares before completion, repayment or payoff at closing, or novation to the buyer. Conversion usually requires shareholder approval and a share issuance, which takes time and must be sequenced into the timetable; a buyer cannot assume it happens instantly on signing. The economics also depend on whether the instrument is pre-money or post-money, because that affects how the converted shares dilute existing holders and, consequently, how the purchase price should be allocated. Where conversion terms are uncertain or disputed, the resulting cap-table ambiguity can materially affect what the buyer is actually acquiring.

Tax consequences may arise on conversion or repayment and should be assessed in advance.

Practical deal solutions

The cleanest approach is to resolve convertibles before or at closing under agreed mechanics, supported by buyer protections. Where conversion outcomes remain uncertain, escrow can hold back part of the consideration until the cap table is settled, and purchase-price adjustment clauses can true up the economics. A negotiation checklist for convertibles should include:

• Require representations and warranties listing every outstanding convertible instrument.
• Agree whether each instrument converts, is repaid or is rolled over, and on what terms.
• Build escrow or holdbacks for uncertain or disputed conversions.
• Include indemnities and purchase-price adjustments to absorb cap-table surprises.
• Sequence any required shareholder approvals and share issuances into the closing timetable.

Governance and control rights, founder vetoes, share classes and protective provisions

Control is often as important as price. A buyer acquiring a majority stake, but not 100%, must understand what founders and remaining investors can block, and how exit mechanics operate.

Typical control rights matrix in a PSA or startup SPA

Startup shareholders’ agreements commonly reserve certain matters, raising new capital, issuing new shares, incurring major debt, amending the charter, or selling key assets, to supermajority or specific-holder approval. In a PSA, these protective provisions are often tied to particular share classes, which means a buyer must identify every reserved matter and every class right before signing. Where founders retain a minority stake, buyers should negotiate clear limits on reserved matters, sunset clauses that phase out founder vetoes over time, and robust drag-along and tag-along provisions so that a future exit is not held hostage by a small minority.

Dematerialised shares and share transfer restrictions

Because PSA shares are dematerialised, transfer restrictions operate through the share register and the charter rather than through physical certificates. Pre-emption rights, approval requirements and lock-ups must all be checked, since they can delay or complicate both the acquisition itself and any later disposal. A buyer’s governance package should align the register, the charter and the shareholders’ agreement so that control rights are consistent across all three documents.

Merger control and UOKiK triggers: when to notify and practical timing

Merger control is the regulatory touchpoint most often underestimated in startup M&A Poland. Even where the target is small, a filing to UOKiK may be required if the parties’ combined turnover meets the statutory thresholds under the Act on Competition and Consumer Protection. Getting this analysis wrong can delay or unwind a deal.

UOKiK filing thresholds and cross-border considerations

Polish merger control is assessed by reference to turnover thresholds, and the analysis considers group-level figures, not just the target’s standalone revenue. This is why a modest startup can still fall within scope, if the acquirer is a large strategic or a well-capitalised group, the combined turnover can exceed the thresholds even though the target is tiny. The current monetary thresholds, together with available exemptions (such as those for small target turnover), should be verified against UOKiK’s official guidance, as they are set in statute and may be updated.

Where a transaction has an EU dimension, the interplay between national and EU merger control must also be considered: the EU Merger Regulation (Council Regulation (EC) No 139/2004) governs when a concentration has an EU dimension and is reviewed by the European Commission rather than by national authorities. Buyers should run the threshold analysis early and confirm the correct forum before committing to a timetable.

Timing, what to include and process

Where a UOKiK notification is required, it becomes a closing condition, and the transaction cannot complete until clearance is obtained. The notification requires detailed information about the parties, their turnover, market shares and the structure of the transaction. UOKiK reviews are conducted in phases, with a longer period available for more complex cases; current statutory review periods should be confirmed against UOKiK’s guidance. Buyers should build a provisional timeline that accounts for the review period, prepare the required documents in parallel with the SPA, and make completion conditional on clearance. Starting the analysis late is one of the most common causes of deal slippage.

Practical tips for structuring

Structuring choices, such as an asset versus share route, or staggered acquisitions, can in some circumstances affect the merger-control analysis, but these must be approached with care and never used artificially to evade a mandatory filing. Any structuring intended to influence notifiability should be reviewed with competition counsel to ensure it is lawful and robust. Buyers should also consider whether a transaction engages Poland’s foreign-investment screening regime, which can apply to acquisitions in certain protected sectors.

Practical deal clauses and negotiation checklist

A well-drafted SPA does the heavy lifting of risk allocation in startup M&A Poland. Twelve priority clauses buyers should focus on:

1. Completion mechanics, including share-register updates for a PSA.
2. Escrow and holdbacks to secure indemnity claims.
3. Representations and warranties covering title, cap table and IP.
4. Indemnities with an agreed cap and basket.
5. Earn-outs tied to clear, measurable milestones.
6. Employee retention and incentive arrangements.
7. IP representations confirming valid assignments.
8. Treatment of all outstanding convertible instruments.
9. Closing conditions, including any UOKiK clearance.
10. Tax covenants allocating pre-closing tax exposure.
11. Post-closing integration covenants.
12. Governance and control provisions, including drag and tag rights.

Post-closing integration and employment transitions

Closing is the beginning, not the end. The early integration phase determines whether the acquisition delivers value. Priorities include onboarding founders and aligning them with incentive and retention arrangements, administering any ESOP trusts, pools or new grants, ensuring licences and key contracts continue without interruption, and confirming that the share register and corporate records reflect the new ownership. The most common integration pitfalls are losing key talent through poorly structured retention, and allowing contracts with change-of-control clauses to lapse because consents were not obtained in time.

Sample timeline and 30/60/90-day buyer playbook

A practical timeline for startup M&A Poland runs from letter of intent through to post-closing integration:

• Days 1–30. Execute the LOI, launch due diligence, pull KRS/eKRS extracts, reconcile the cap table and begin the UOKiK threshold analysis.
• Days 31–60. Negotiate the SPA and disclosure, agree ESOP and convertible-instrument treatment, prepare any merger-control notification and finalise governance terms.
• Days 61–90. Satisfy closing conditions, obtain clearances and consents, complete the share-register update, and begin integration and employment transitions.

Next steps on your startup M&A Poland transaction

Startup M&A Poland rewards buyers who front-load the hard questions, entity form, cap-table integrity, ESOP mechanics, convertible-instrument treatment and merger control, rather than leaving them for the closing checklist. With state-backed acceleration feeding new dealflow in 2026, the opportunities for foreign acquirers are real, but so is the legal complexity of PSAs, dematerialised shares and bespoke share classes. A disciplined, well-documented approach to startup M&A Poland, grounded in verified registers and tested clauses, is the surest route to a deal that completes cleanly and delivers value after closing.

For deal clinics, sample SPA and annex drafting, ESOP structuring and UOKiK filing support, contact the Poland M&A practice page or browse the GLE lawyer directory, Poland M&A filters to connect with specialist counsel.

Image alt: Cross-border acquisition of a Polish startup, startup m&a poland contract signing and due diligence.

Sources

1. PARP, Polish Agency for Enterprise Development
2. UOKiK, Office of Competition and Consumer Protection
3. EUR-Lex, Council Regulation (EC) No 139/2004 (EU Merger Regulation)
4. ISAP, Kodeks spółek handlowych (Commercial Companies Code)
5. Gov.pl, Ministry of Justice
6. National Court Register (eKRS / KRS), Ministry of Justice
7. Gov.pl, Ministry of Finance (tax guidance)